Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fish Oils | 7 | 2014 | 43 | 2.800 |
Why?
|
| Dietary Fats, Unsaturated | 5 | 2014 | 31 | 2.130 |
Why?
|
| Short Bowel Syndrome | 4 | 2012 | 16 | 1.490 |
Why?
|
| Infant, Premature | 5 | 2014 | 73 | 1.430 |
Why?
|
| Intestinal Absorption | 4 | 2014 | 22 | 1.430 |
Why?
|
| Enteral Nutrition | 4 | 2014 | 34 | 1.370 |
Why?
|
| Intestinal Mucosa | 3 | 2014 | 74 | 1.140 |
Why?
|
| Enterostomy | 3 | 2014 | 7 | 1.030 |
Why?
|
| Intestines | 3 | 2014 | 64 | 0.930 |
Why?
|
| Fat Emulsions, Intravenous | 2 | 2014 | 11 | 0.910 |
Why?
|
| Adaptation, Physiological | 2 | 2014 | 57 | 0.810 |
Why?
|
| Dietary Supplements | 3 | 2014 | 188 | 0.570 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 1017 | 0.540 |
Why?
|
| Dietary Proteins | 1 | 2014 | 56 | 0.450 |
Why?
|
| Infant, Newborn | 5 | 2014 | 673 | 0.450 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2010 | 37 | 0.420 |
Why?
|
| Dietary Fats | 1 | 2013 | 111 | 0.420 |
Why?
|
| Fats | 1 | 2012 | 3 | 0.410 |
Why?
|
| Bile Acids and Salts | 1 | 2012 | 9 | 0.410 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2012 | 11 | 0.410 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 26 | 0.400 |
Why?
|
| Deglutition Disorders | 1 | 2012 | 52 | 0.390 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 28 | 0.390 |
Why?
|
| Ileocecal Valve | 1 | 2010 | 2 | 0.350 |
Why?
|
| Jejunum | 1 | 2010 | 6 | 0.350 |
Why?
|
| Colon | 1 | 2010 | 52 | 0.340 |
Why?
|
| Echium | 1 | 2009 | 11 | 0.340 |
Why?
|
| Plant Oils | 1 | 2009 | 17 | 0.330 |
Why?
|
| Feces | 3 | 2014 | 40 | 0.310 |
Why?
|
| Lipids | 1 | 2009 | 229 | 0.300 |
Why?
|
| Rats | 4 | 2012 | 1596 | 0.270 |
Why?
|
| Liver | 1 | 2009 | 483 | 0.270 |
Why?
|
| Postoperative Complications | 1 | 2010 | 785 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 745 | 0.220 |
Why?
|
| Body Weight | 2 | 2014 | 310 | 0.190 |
Why?
|
| Ileum | 2 | 2012 | 17 | 0.190 |
Why?
|
| Male | 6 | 2014 | 19195 | 0.180 |
Why?
|
| Anastomosis, Surgical | 2 | 2010 | 61 | 0.180 |
Why?
|
| Diarrhea | 2 | 2010 | 62 | 0.180 |
Why?
|
| Animals | 4 | 2012 | 7466 | 0.160 |
Why?
|
| Female | 4 | 2014 | 19953 | 0.130 |
Why?
|
| Ostomy | 1 | 2014 | 1 | 0.120 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 15 | 0.120 |
Why?
|
| Humans | 5 | 2014 | 32024 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2014 | 98 | 0.110 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2012 | 1 | 0.100 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cholestenones | 1 | 2012 | 2 | 0.100 |
Why?
|
| Cecum | 1 | 2012 | 9 | 0.100 |
Why?
|
| Food Additives | 1 | 2012 | 2 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 90 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2012 | 45 | 0.100 |
Why?
|
| Cholestasis | 1 | 2010 | 19 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 377 | 0.090 |
Why?
|
| Infant | 1 | 2014 | 1061 | 0.090 |
Why?
|
| alpha-Glucosidases | 1 | 2010 | 3 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 565 | 0.090 |
Why?
|
| Weaning | 1 | 2010 | 7 | 0.090 |
Why?
|
| Hyperphagia | 1 | 2010 | 4 | 0.090 |
Why?
|
| Growth Disorders | 1 | 2010 | 6 | 0.090 |
Why?
|
| Weight Gain | 1 | 2010 | 118 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2010 | 464 | 0.080 |
Why?
|
| Milk | 1 | 2009 | 17 | 0.080 |
Why?
|
| Organ Size | 1 | 2010 | 210 | 0.080 |
Why?
|
| RNA | 1 | 2010 | 92 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2009 | 115 | 0.080 |
Why?
|
| Proteins | 1 | 2010 | 145 | 0.080 |
Why?
|
| DNA | 1 | 2010 | 228 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 2152 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 2280 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2012 | 1435 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3317 | 0.050 |
Why?
|
| Brain | 1 | 2009 | 950 | 0.050 |
Why?
|